Skip to main content
. Author manuscript; available in PMC: 2010 Jul 6.
Published in final edited form as: J Am Geriatr Soc. 2008 Sep 22;56(10):1867–1872. doi: 10.1111/j.1532-5415.2008.01950.x

Table 3.

Risk of worsening white matter hyperintensities (WMH) ≥1 grade in anemic participants with and without high blood pressure (measured blood pressure ≥140/90), compared to non-anemic ones. Multivariable logistic regression models.

Model Adjustment Factors* OR (95%CI) for WMH change ≥1 grade

BP < 140/90 BP ≥ 140/90
N=1168 N=678
A Demographics 0.74 (0.48–1.15) 1.69 (1.03–2.82)
B A + Baseline WMH grade and time between scans 0.75 (0.48–1.16) 1.74 (1.04–1.92)

C B + Vascular risk factors and comorbidities 0.77 (0.49–1.21) 1.83 (1.07–3.15)
D B + Measures of vascular disease 0.70 (0.44–1.11) 1.84 (1.08–3.06)
E B + History of stroke 0.74 (0.48–1.14) 1.70 (1.02–3.29)
F B + Cystatin C 0.72 (0.46–1.14) 1.60 (1.01–2.70)
G B + Inflammation 0.74 (0.48–1.17) 1.59 (1.01–2.83)
H B + Medications 0.73 (0.47–1.13) 1.69 (1.01–2.82)
I B + Incident stroke 0.76 (0.49–1.18) 1.68 (1.02–2.83)

Fully adjusted 0.68 (0.41–1.10) 1.79 (1.03–2.98)
*

Models are adjusted for the following variables:

A. Age, gender and race.

B. Model A + baseline WMH grade and time between the scans.

C. Model B + body mass index, diabetes, smoking status (current/past Vs. never), LDL, HDL, dizziness, factor VII and prevalent cardiovascular diseases.

D. Model B + ankle-arm index, left ventricular hypertrophy by ECG

E. Model B + history of stroke

F. Model B + Cystatin C

G. Model B + inflammation (at least two of: low albumin, high CRP, white blood cells, fibrinogen)

H. Model B + lowering-lipid medications, antihypertensive medications and aspirin use.

I. Model B + strokes between the two MRI scans.

Fully adjusted: adjusted for all the above mentioned covariates.